Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects
- PMID: 26935837
- PMCID: PMC4877443
- DOI: 10.1530/ERC-16-0082
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects
Abstract
Somatic mosaicism has been implicated as a causative mechanism in a number of genetic and genomic disorders. X-linked acrogigantism (XLAG) syndrome is a recently characterized genomic form of pediatric gigantism due to aggressive pituitary tumors that is caused by submicroscopic chromosome Xq26.3 duplications that include GPR101 We studied XLAG syndrome patients (n= 18) to determine if somatic mosaicism contributed to the genomic pathophysiology. Eighteen subjects with XLAG syndrome caused by Xq26.3 duplications were identified using high-definition array comparative genomic hybridization (HD-aCGH). We noted that males with XLAG had a decreased log2ratio (LR) compared with expected values, suggesting potential mosaicism, whereas females showed no such decrease. Compared with familial male XLAG cases, sporadic males had more marked evidence for mosaicism, with levels of Xq26.3 duplication between 16.1 and 53.8%. These characteristics were replicated using a novel, personalized breakpoint junction-specific quantification droplet digital polymerase chain reaction (ddPCR) technique. Using a separate ddPCR technique, we studied the feasibility of identifying XLAG syndrome cases in a distinct patient population of 64 unrelated subjects with acromegaly/gigantism, and identified one female gigantism patient who had had increased copy number variation (CNV) threshold for GPR101 that was subsequently diagnosed as having XLAG syndrome on HD-aCGH. Employing a combination of HD-aCGH and novel ddPCR approaches, we have demonstrated, for the first time, that XLAG syndrome can be caused by variable degrees of somatic mosaicism for duplications at chromosome Xq26.3. Somatic mosaicism was shown to occur in sporadic males but not in females with XLAG syndrome, although the clinical characteristics of the disease were similarly severe in both sexes.
Keywords: X-LAG syndrome; gigantism; molecular genetics; mosaicism; pituitary.
© 2016 Society for Endocrinology.
Figures
Similar articles
-
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.Acta Neuropathol Commun. 2016 Jun 1;4(1):56. doi: 10.1186/s40478-016-0328-1. Acta Neuropathol Commun. 2016. PMID: 27245663 Free PMC article.
-
Gigantism: X-linked acrogigantism and GPR101 mutations.Growth Horm IGF Res. 2016 Oct-Dec;30-31:64-69. doi: 10.1016/j.ghir.2016.09.007. Epub 2016 Sep 29. Growth Horm IGF Res. 2016. PMID: 27743704 Review.
-
X-Linked Acrogigantism.2018 Feb 1. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2018 Feb 1. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 29389097 Free Books & Documents. Review.
-
Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.J Clin Endocrinol Metab. 2016 May;101(5):1927-30. doi: 10.1210/jc.2015-4366. Epub 2016 Mar 16. J Clin Endocrinol Metab. 2016. PMID: 26982009 Free PMC article.
-
Mutations in GPR101 as a potential cause of X-linked acrogigantism and acromegaly.Prog Mol Biol Transl Sci. 2019;161:47-67. doi: 10.1016/bs.pmbts.2018.10.003. Epub 2018 Nov 23. Prog Mol Biol Transl Sci. 2019. PMID: 30711029 Review.
Cited by
-
Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS).Genes (Basel). 2024 Jan 18;15(1):120. doi: 10.3390/genes15010120. Genes (Basel). 2024. PMID: 38255009 Free PMC article.
-
An update on, and genetics of refractory adenomas of childhood.Pituitary. 2023 Jun;26(3):281-287. doi: 10.1007/s11102-023-01327-2. Epub 2023 Jun 15. Pituitary. 2023. PMID: 37318708 Review.
-
Pituitary Tumorigenesis-Implications for Management.Medicina (Kaunas). 2023 Apr 21;59(4):812. doi: 10.3390/medicina59040812. Medicina (Kaunas). 2023. PMID: 37109772 Free PMC article. Review.
-
The Spectrum of Familial Pituitary Neuroendocrine Tumors.Endocr Pathol. 2023 Mar;34(1):57-78. doi: 10.1007/s12022-022-09742-0. Epub 2022 Nov 18. Endocr Pathol. 2023. PMID: 36401106 Review.
-
The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway.Front Endocrinol (Lausanne). 2022 Oct 13;13:1024423. doi: 10.3389/fendo.2022.1024423. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36313756 Free PMC article. Review.
References
-
- Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, Vale W. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology. 1992;131:2083–2089. - PubMed
-
- Ballif BC, Rorem EA, Sundin K, Lincicum M, Gaskin S, Coppinger J, Kashork CD, Shaffer LG, Bejjani BA. Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet A. 2006;140:2757–2767. - PubMed
-
- Bates B, Zhang L, Nawoschik S, Kodangattil S, Tseng E, Kopsco D, Kramer A, Shan Q, Taylor N, Johnson J, et al. Characterization of Gpr101 expression and G-protein coupling selectivity. Brain Res. 2006;1087:1–14. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
